Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
grade D 12.23 0.00% 0.00
SCPH closed unchanged on Wednesday, January 17, 2018, on 32 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical SCPH trend table...

Date Alert Name Type % Chg
Jan 17 Narrow Range Bar Range Contraction 0.00%
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 Narrow Range Bar Range Contraction 0.00%
Jan 16 Inside Day Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 12 Wide Bands Range Expansion 1.92%
Jan 11 Inside Day Range Contraction -0.16%
Jan 11 Wide Bands Range Expansion -0.16%
Jan 10 Outside Day Range Expansion -0.16%

Older signals for SCPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.
Is SCPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.17
52 Week Low 11.5
Average Volume 64,425
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 12.3356
10-Day Moving Average 12.0961
Average True Range 0.7694
ADX 9.62
+DI 17.83
-DI 20.8
Chandelier Exit (Long, 3 ATRs ) 12.0818
Chandelier Exit (Short, 3 ATRs ) 13.8082
Upper Bollinger Band 13.26
Lower Bollinger Band 11.4112
Percent B (%b) 0.44
BandWidth 14.987516
MACD Line -0.5963
MACD Signal Line -0.7151
MACD Histogram 0.1188
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.65
Resistance 3 (R3) 12.69 12.60 12.58
Resistance 2 (R2) 12.60 12.49 12.58 12.56
Resistance 1 (R1) 12.41 12.42 12.37 12.37 12.53
Pivot Point 12.32 12.32 12.30 12.30 12.32
Support 1 (S1) 12.13 12.21 12.09 12.09 11.93
Support 2 (S2) 12.04 12.14 12.02 11.90
Support 3 (S3) 11.85 12.04 11.88
Support 4 (S4) 11.81